(AP Photo/Darron Cummings, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

For the past year, Jonsson has run Lilly Diabetes and Obesity, which means he oversees everything from insulin shots to the newer, high-demand drugs now known as "weight-loss" shots: Mounjaro ...